Fresenius Propoven 2%
- Product NDC
- 18124-027
- 11-digit product format
- 181240027
- Labeler code
- 18124
- Product ID
- 18124-027_c1afda43-82cc-4336-953c-ac430d95821e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- PROPOFOL
- Dosage form
- EMULSION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi Austria GmbH
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2020-06-05
- Marketing end
- 0000-00-00
- Substance
- PROPOFOL
- Active strength
- 20 mg/mL
- Pharmacologic classes
- General Anesthesia [PE],General Anesthetic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status.
Dataset, Scope, Product NDC table| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|
| excluded product | product | 18124-027 | | D | Discontinued by firm | | 2026-07-31 |
| excluded package | package | 18124-027 | 18124-027-00 | D | Discontinued by firm | | 2026-07-31 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 18124-027-00 | 18124002700 | 10 VIAL in 1 BOX (18124-027-00) > 100 mL in 1 VIAL | 10 vial | 2020-06-05 | 0000-00-00 | No | No | Current |